{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:45:37Z","timestamp":1791002737046,"version":"4.1.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T00:00:00Z","timestamp":1548028800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Netherlands Ministry of Health Welfare and Sports"},{"name":"Stoffels-Hornstra Foundation"},{"name":"Dutch Alzheimer Association"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/gerona\/glz019","type":"journal-article","created":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T15:09:39Z","timestamp":1548083379000},"source":"Crossref","is-referenced-by-count":25,"title":["Long-Term Exposure to Anticholinergic and Sedative Medications and Cognitive and Physical Function in Later Life"],"prefix":"10.1093","author":[{"given":"Hans","family":"Wouters","sequence":"first","affiliation":[{"name":"Department of PharmacoTherapy, -Epidemiology & -Economics, Faculty of Science and Engineering, University of Groningen, The Netherlands"},{"name":"Department of General Practice and Elderly Care Medicine, University of Groningen, University Medical Center Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah N","family":"Hilmer","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Aged Care, Kolling Institute, Royal North Shore Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijela","family":"Gnjidic","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy and Charles Perkins Centre, University of Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos P","family":"Van Campen","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Onze Lieve Vrouwe Gasthuis (OLVG) hospital, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Teichert","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene G","family":"Van Der Meer","sequence":"additional","affiliation":[{"name":"Department of PharmacoTherapy, -Epidemiology & -Economics, Faculty of Science and Engineering, University of Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A","family":"Schaap","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Faculty of Earth & Life Sciences, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Huisman","sequence":"additional","affiliation":[{"name":"Department of Epidemiology & Biostatistics, Amsterdam UMC, Location VUmc, The Netherlands"},{"name":"Department of Sociology, VU University, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannie C","family":"Comijs","sequence":"additional","affiliation":[{"name":"Department Psychiatry, Amsterdam UMC, Location VUmc, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Denig","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine J","family":"Lamoth","sequence":"additional","affiliation":[{"name":"Center of Human Movement Science, University of Groningen, University Medical Center Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Taxis","sequence":"additional","affiliation":[{"name":"Department of PharmacoTherapy, -Epidemiology & -Economics, Faculty of Science and Engineering, University of Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,1,21]]},"reference":[{"key":"2019051006392826500_CIT0001","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12916-015-0322-7","article-title":"The rising tide of polypharmacy and drug\u2013drug interactions: population database analysis 1995\u20132010","volume":"13","author":"Guthrie","year":"2015","journal-title":"BMC Med."},{"key":"2019051006392826500_CIT0002","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/gerona\/glv013","article-title":"Polypharmacy among adults aged 65 years and older in the United States: 1988\u20132010","volume":"70","author":"Charlesworth","year":"2015","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"2019051006392826500_CIT0003","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.amjopharm.2006.03.008","article-title":"Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events","volume":"4","author":"Ness","year":"2006","journal-title":"Am J Geriatr Pharmacother."},{"key":"2019051006392826500_CIT0004","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/gps.2189","article-title":"The use of benzodiazpines and related drugs amongst older people in Sweden: associated factors and concomitant use of other psychotropics","volume":"24","author":"Johnell","year":"2009","journal-title":"Int J Geriatr Psychiatry."},{"key":"2019051006392826500_CIT0005","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/ageing\/afu096","article-title":"Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review","volume":"43","author":"Fox","year":"2014","journal-title":"Age Ageing."},{"key":"2019051006392826500_CIT0006","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/bmj.38740.439664.DE","article-title":"Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study","volume":"332","author":"Ancelin","year":"2006","journal-title":"BMJ."},{"key":"2019051006392826500_CIT0007","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0009-9236(98)90059-5","article-title":"Benzodiazepine use and cognitive function among community-dwelling elderly","volume":"64","author":"Hanlon","year":"1998","journal-title":"Clin Pharmacol Ther."},{"key":"2019051006392826500_CIT0008","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1532-5415.2008.02127.x","article-title":"Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: findings from the Health, Aging and Body Composition Study","volume":"57","author":"Wright","year":"2009","journal-title":"J Am Geriatr Soc."},{"key":"2019051006392826500_CIT0009","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/gerona\/glt192","article-title":"Long-term cognitive and functional effects of potentially inappropriate medications in older women","volume":"69","author":"Koyama","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"2019051006392826500_CIT0010","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1046\/j.1532-5415.2003.51502.x","article-title":"Benzodiazepine use and physical performance in community-dwelling older women","volume":"51","author":"Gray","year":"2003","journal-title":"J Am Geriatr Soc."},{"key":"2019051006392826500_CIT0011","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/gly176","article-title":"Drug burden index and its association with hip fracture among older adults: a national population-based study","author":"Jamieson","year":"2018","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"2019051006392826500_CIT0012","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1517\/14740338.2016.1165664","article-title":"Anticholinergics: theoretical and clinical overview","volume":"15","author":"Nishtala","year":"2016","journal-title":"Expert Opin Drug Saf."},{"key":"2019051006392826500_CIT0013","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/bcpt.12140","article-title":"Anticholinergic drug burden in older people\u2019s brain\u2014how well is it measured?","volume":"114","author":"Kersten","year":"2014","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"2019051006392826500_CIT0014","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1073\/pnas.012467899","article-title":"Functional MRI detection of pharmacologically induced memory impairment","volume":"99","author":"Sperling","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"2019051006392826500_CIT0015","first-page":"149","volume-title":"Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics","author":"Hardman","year":"1996"},{"key":"2019051006392826500_CIT0016","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1532-5415.1997.tb05167.x","article-title":"Effect of a single dose of diazepam on balance measures in older people","volume":"45","author":"Cutson","year":"1997","journal-title":"J Am Geriatr Soc."},{"key":"2019051006392826500_CIT0017","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/gerona\/glr170","article-title":"Muscle strength and sedative load in community-dwelling people aged 75 years and older: a population-based study","volume":"66","author":"Taipale","year":"2011","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"2019051006392826500_CIT0018","doi-asserted-by":"crossref","first-page":"1142.e1","DOI":"10.1016\/j.amjmed.2009.02.021","article-title":"Drug burden index score and functional decline in older people","volume":"122","author":"Hilmer","year":"2009","journal-title":"Am J Med."},{"key":"2019051006392826500_CIT0019","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/ageing\/afr102","article-title":"The impact of anticholinergic burden in Alzheimer\u2019s dementia\u2014the LASER-AD study","volume":"40","author":"Fox","year":"2011","journal-title":"Age Ageing."},{"key":"2019051006392826500_CIT0020","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/gps.1811","article-title":"The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent?","volume":"22","author":"Bierman","year":"2007","journal-title":"Int J Geriatr Psychiatry."},{"key":"2019051006392826500_CIT0021","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study","volume":"175","author":"Gray","year":"2015","journal-title":"JAMA Intern Med."},{"key":"2019051006392826500_CIT0022","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-2012-110935","article-title":"Anticholinergic drugs in late life: adverse effects on cognition but not on progress to dementia","volume":"30","author":"Whalley","year":"2012","journal-title":"J Alzheimers Dis."},{"key":"2019051006392826500_CIT0023","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jamaneurol.2016.0580","article-title":"Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults","volume":"73","author":"Risacher","year":"2016","journal-title":"JAMA Neurol."},{"key":"2019051006392826500_CIT0024","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinte.167.8.781","article-title":"A drug burden index to define the functional burden of medications in older people","volume":"167","author":"Hilmer","year":"2007","journal-title":"Arch Intern Med."},{"key":"2019051006392826500_CIT0025","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/ije\/dyq219","article-title":"Cohort profile: the Longitudinal Aging Study Amsterdam","volume":"40","author":"Huisman","year":"2011","journal-title":"Int J Epidemiol."},{"key":"2019051006392826500_CIT0026","volume-title":"Anatomical Therapeutic Chemical (ATC) Classification Index","author":"WHO Collaborating Centre for Drug Statistics Methodology","year":"2017"},{"key":"2019051006392826500_CIT0027","doi-asserted-by":"crossref","first-page":"e009213","DOI":"10.1136\/bmjopen-2015-009213","article-title":"Decreasing the load? Is a multidisciplinary multistep medication review in older people an effective intervention to reduce a patient\u2019s drug burden index? Protocol of a randomised controlled trial","volume":"5","author":"van der Meer","year":"2015","journal-title":"BMJ Open."},{"key":"2019051006392826500_CIT0028","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res."},{"key":"2019051006392826500_CIT0029","volume-title":"Alphabet Coding Task 15","author":"Savage","year":"1984"},{"key":"2019051006392826500_CIT0030","article-title":"Functiestoornissen na trauma capitis (Cognitive impairment after trauma capitis)","volume-title":"Neuropsychologie in Nederland (Neuropsychology in the Netherlands)","author":"Deelman","year":"1980"},{"key":"2019051006392826500_CIT0031","volume-title":"Manual for the Coloured Progressive Matrices (revised)","author":"Raven","year":"1985"},{"key":"2019051006392826500_CIT0032","doi-asserted-by":"crossref","first-page":"M141","DOI":"10.1093\/geronj\/44.5.M141","article-title":"Physical performance measures in aging research","volume":"44","author":"Guralnik","year":"1989","journal-title":"J Gerontol."},{"key":"2019051006392826500_CIT0033","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D scale: a self-report depression scale for research in the general population","volume":"3","author":"Radloff","year":"1977","journal-title":"Appl Psychol Measure."},{"key":"2019051006392826500_CIT0034","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/sj.clpt.6100303","article-title":"Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women","volume":"83","author":"Cao","year":"2008","journal-title":"Clin Pharmacol Ther."},{"key":"2019051006392826500_CIT0035","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/jgs.12632","article-title":"Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline","volume":"62","author":"Kashyap","year":"2014","journal-title":"J Am Geriatr Soc."},{"key":"2019051006392826500_CIT0036","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/fampra\/cmx018","article-title":"Late-life depression and the association with multimorbidity and polypharmacy: a cross-sectional study","volume":"34","author":"Holvast","year":"2017","journal-title":"Fam Pract."},{"key":"2019051006392826500_CIT0037","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2147\/CIA.S66660","article-title":"Drug burden index in older adults: theoretical and practical issues","volume":"9","author":"Kouladjian","year":"2014","journal-title":"Clin Interv Aging."},{"key":"2019051006392826500_CIT0038","doi-asserted-by":"crossref","first-page":"609","DOI":"10.7326\/M16-2729","article-title":"Discontinuing inappropriate medication use in nursing home residents: a cluster randomized controlled trial","volume":"167","author":"Wouters","year":"2017","journal-title":"Ann Intern Med."},{"key":"2019051006392826500_CIT0039","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/gerona\/gls176","article-title":"Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial","volume":"68","author":"Kersten","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"2019051006392826500_CIT0040"},{"key":"2019051006392826500_CIT0041","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/bcp.12670","article-title":"Measuring anticholinergic drug exposure in older community-dwelling Australian men: a comparison of four different measures","volume":"80","author":"Pont","year":"2015","journal-title":"Br J Clin Pharmacol."}],"container-title":["The Journals of Gerontology: Series A"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/biomedgerontology\/advance-article-pdf\/doi\/10.1093\/gerona\/glz019\/28579886\/glz019.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/biomedgerontology\/advance-article-pdf\/doi\/10.1093\/gerona\/glz019\/27566780\/glz019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T10:48:09Z","timestamp":1557485289000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/advance-article\/doi\/10.1093\/gerona\/glz019\/5298370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,21]]},"references-count":41,"URL":"https:\/\/doi.org\/10.1093\/gerona\/glz019","relation":{},"ISSN":["1079-5006","1758-535X"],"issn-type":[{"value":"1079-5006","type":"print"},{"value":"1758-535X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,21]]},"article-number":"glz019"}}